Tailoring an Online Platform to Promote Evidence-Based Care for Adults With Neurofibromatosis 1 and Low Health Literacy
Part of paid clinical trials in Boston, Massachusetts.
- Sponsor
- Massachusetts General Hospital
- Study ID
- NCT07233408
- Status
- Recruiting
Conditions
- Neurofibromatosis 1
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- NF1 Educational Videos — OTHERParticipants will receive access to NF1 educational videos that further explain NF1 health surveillance recommendations in advance of the patient's annual wellness visit.
- Peer Navigator — OTHERParticipants will receive a phone or video call from an NF1 peer navigator. The navigator will explain NF1 health surveillance recommendations and coach individuals on how to discuss these recommendations with their provider.
- Letters about NF1 Care — OTHERParticipants will receive two letters about NF1 care, one for themselves and one for their primary care clinician, to read in advance of the patient's annual wellness visit.
Study Details
This decentralized, randomized study seeks to assess the feasibility, acceptability, and preliminary effectiveness of two approaches to assisting Neurofibromatosis 1 (NF1) patients with low health literacy improve their understanding of NF1 symptoms and care recommendations. Participants will be provided with personalized NF1 care letters for themselves and their doctors, along with either NF1 educational videos or a call with an NF1 peer navigator. Adults with NF1 from across the U.S. who have upcoming annual wellness visits scheduled with a primary care provider (PCP) are eligible to enroll in the study. To see if you might be eligible, fill out a prescreening survey here: https://redcap.link/nfpeer
Key Dates
- Start date
- Dec 28, 2025
- Status verified
- Dec 2025
- Primary completion
- May 30, 2026
- Completion
- May 30, 2026
Study Design
- Enrollment
- 50 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- HEALTH_SERVICES_RESEARCH
Arms
- Experimental: NF1 Educational Videos
- Experimental: Peer Navigator
Primary Outcome Measure
Feasibility of Videos and NF1 Peer Navigator Use as an Addition to My NF Guide [ Time Frame: 2 weeks after PCP visit ]
Central Contacts
- Paulina Arias Hernandez, MSW617-724-5321
- Annika Coleman, BS857-282-2167
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Massachusetts General Hospital | Boston | Massachusetts | 02114 |
Find similar trials in Boston, MA
Related Studies
- Selumetinib for the Prevention of Plexiform Neurofibroma Growth in NF Type 1PHASE2 · Recruiting · University of Alabama at Birmingham · Birmingham, Alabama
- A Decentralized Clinical Trial to Promote Evidence-Based Care for Underserved Patients With Neurofibromatosis 1Recruiting · Massachusetts General Hospital · Boston, Massachusetts
- Assessing the Efficacy of Repeat, Monthly Treatments of Deoxycholate for NF1 Associated Cutaneous Neurofibromas (cNFs)PHASE1 · Enrolling By Invitation · Massachusetts General Hospital · Boston, Massachusetts
- Neurofibromatosis Type 1 Tumor Early Detection StudyRecruiting · David Miller · Boston, Massachusetts